Severity of BA.2 variant and vaccine effectiveness against symptomatic disease in Scotland. (2022)
Attributed to:
Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100533
PubMed Identifier: 36373099
Publication URI: http://europepmc.org/abstract/MED/36373099
Type: Journal Article/Review
Volume: 23
Parent Publication: The Lancet regional health. Europe
ISSN: 2666-7762